Le Lézard
Classified in: Ebola virus, Health
Subjects: AWD, EXE

Joint Statement from the Minister of Health and the Chief Public Health Officer Congratulating 2017 Ernest C. Manning Foundation Principal Award Recipients



OTTAWA, Nov. 30, 2017 /CNW/ - The Honourable Ginette Petitpas Taylor, Minister of Health, and Dr. Theresa Tam, Chief Public Health Officer, today issued the following joint statement to congratulate the recipients of the 2017 Ernest C. Manning Foundation Principal Award:

"On behalf of the Government of Canada, we extend our heartfelt congratulations to Dr. Xiangguo Qiu and Dr. Gary Kobinger who received the prestigious 2017 Ernest C. Manning Foundation Principal Award yesterday evening for their valuable contributions to the global effort to fight Ebola virus disease. The discoveries in Ebola research made by these scientists and their colleagues at the National Microbiology Laboratory have been recognized internationally as changing the course of research in this field. Today, Drs. Qiu and Kobinger are being awarded for the development of a promising experimental Ebola treatment and vaccine that saved lives during the West African outbreak.

"The Principal Award is the highest honour of several awards that the Ernest C. Manning Foundation grants annually to talented Canadian innovators who are improving the lives of Canadians and others worldwide through their commercialized innovations. It is another example of the outstanding work that is done by our Government of Canada scientists.

"The team from the National Microbiology Laboratory have earned international status as leaders in scientific research for the deadliest of infectious diseases. Canadians should be proud of their innovative work and discoveries, which have had an immense impact on global health."

 

SOURCE Public Health Agency of Canada


These press releases may also interest you

at 02:00
A Sioux Falls company, OmegaQuant, LLC has reached an agreement with the Office of In Vitro Diagnostics and Radiological Health of the Food and Drug Administration (FDA) that allows OmegaQuant to market its Omega-3 Indextm test as an over the...

at 02:00
Provide your body with the support it needs to fight the effects of oxidative stress.* Pure Encapsulations® Nrf2 Detox with Setria® Glutathione is now available in Germany and Austria. Nrf2 Detox is a three-ingredient blend that contains broccoli...

at 01:30
Regeneron Pharmaceuticals, Inc. today announced updates related to its collaboration programs with Sanofi, which were highlighted during Sanofi's Sustaining Innovation Analyst Day in Paris, France. In a separate release today the companies also...

at 01:01
Regeneron Pharmaceuticals, Inc. and Sanofi today announced positive topline results from a pivotal Phase 2 clinical study of cemiplimab in 82 patients with advanced cutaneous squamous cell carcinoma (CSCC), the second deadliest skin cancer after...

at 01:00
Maximum tolerability, total non-toxicity, and clear results in few sessions: laser therapy in veterinary medicine has all the credentials to successfully tackle common diseases in pets, exotic and equine species.       (Photo:...

12 déc 2017
Blueprint Medicines Corporation , a leader in discovering and developing targeted kinase medicines for patients with genomically defined diseases, today announced the pricing of an underwritten public offering of 3,703,704 shares of its common stock...




News published on 30 november 2017 at 09:00 and distributed by: